Howard G. Smith seeks Fractyl Health investors for securities fraud class action
A law firm press release says investors in Fractyl Health, Inc. who lost money may contact the firm about an alleged securities fraud class action tied to Revita and REMAIN-1.
A PR Newswire release says the Law Offices of Howard G. Smith is asking investors who lost money in Fractyl Health, Inc. (GUTS) to contact the firm about a securities fraud class action before an Oct. 20, 2026, lead-plaintiff deadline.
The release says the case concerns alleged false or misleading statements and omissions about Fractyl Health's business, operations and prospects. It says investors may seek to lead the case or may take no action and remain absent class members.
The press release gives an alleged class period of Jan. 13, 2025, through Jan. 29, 2026. It says the claims center on Revita and on the REMAIN-1 Midpoint Cohort, including allegations that Revita was less effective than represented, that operational issues at one or more clinical sites compromised efficacy results, and that the company's clinical, regulatory and commercial prospects were overstated.
The release also says the ability of the REMAIN-1 Midpoint Cohort to assess Revita's efficacy was overstated. It does not include a court ruling or any response from Fractyl Health.
The release provides contact details for the Law Offices of Howard G. Smith: email [email protected], phone (215) 638-4847, website www.howardsmithlaw.com and address 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020.
What happens next depends on whether investors contact the firm before the stated deadline and whether the case proceeds in court. The press release says investors may retain counsel of their choice or do nothing and stay in the class.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()